top of page

RECOMBINANT GROWTH FACTORS · MANUFACTURED IN SOUTH AFRICA

Affordable recombinant growth factors for in vitro innovation.

High-purity. Animal-origin free. Built for African research.

Immobazyme manufactures recombinant human growth factors — EGF, IGF-1, FGF-2, and TGF-β1 — using a proprietary E. coli expression pipeline that delivers research-grade protein at a fraction of the cost of imported alternatives.

 

Each product is produced to >80–95% purity, sterility tested, and mycoplasma-free, giving researchers and producers the consistent, defined inputs their work demands ; without the import costs that have historically put these reagents out of reach for many African labs.

Why growth factors are out of reach — and why that's changing.

For years, the cost of research-grade recombinant growth factors has been a quiet bottleneck in African labs. Imported from Europe or the US, priced in foreign currency, and shipped under cold-chain conditions that add both cost and risk — the inputs that drive in vitro research have remained disproportionately expensive for universities, emerging biotech companies, and cultivated protein producers in the Global South.

​

The result is compromised experimental design. Researchers dilute growth factors further than recommended to stretch budgets. Labs substitute serum-containing media when defined, animal-free conditions are scientifically preferable. Scale-up experiments get delayed or abandoned. And promising in vitro work stalls before it can reach its potential.

​

Immobazyme was built to change this. By manufacturing recombinant growth factors locally in Stellenbosch, South Africa — using a proprietary E. coli expression system that significantly reduces production cost — we make research-grade protein accessible without compromising on purity, bioactivity, or batch consistency.

Immobazyme partners with CSIR to produce FGF-2

Defined biology
for In Vitro innovation.

molecule.png

High Bioactivity

High Purity

Animal-origin-free bunny

Animal-origin free

Batch consistency

Watch how Immobazyme's partnership with the CSIR is driving the development of locally manufactured growth factors for cellular agriculture in South Africa.

Cultivated Meat

Recombinant growth factors like FGF-2 and IGF-1 drive the proliferation and differentiation of satellite cells in serum-free media — enabling muscle tissue to form and mature at scale without reliance on animal-derived inputs.

Tissue Engineering

TGF-β drives chondrogenic and fibrotic differentiation within scaffold environments, while EGF and IGF-1 support cell proliferation and tissue integration — accelerating the development of functional constructs for regenerative applications.

Organoid Research

EGF and FGF-2 support the self-organisation of stem cells into complex three-dimensional tissue structures, sustaining long-term culture in fully defined conditions that improve reproducibility across experimental models.

Drug Discovery​

Defined, recombinant growth factors produce consistent, well-characterised cell models that behave predictably across assay platforms — reducing variability in compound screening and improving the reliability of preclinical data.

Stem cell Research

FGF-2 maintains pluripotency in human embryonic and induced pluripotent stem cells, while IGF-1 and EGF direct lineage commitment — giving researchers precise, animal-free control over cell fate in defined culture systems.

Diagnostics & Biosensor​

EGF and FGF-2 maintain stable, well-defined cell lines used to validate biosensor signals and calibrate diagnostic platforms — ensuring the biological component of any detection system performs consistently batch to batch.

bottom of page